HRT Financial’s Guardant Health GH Stock Holding History

HRT Financial’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,200	Closed	-$441K	–	2703
2022 Q3	$441K	Buy	+8,200	New	+$421K	﹤0.01%	1722

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's GH Position: Q1 2026 in Review

HRT Financial sold out of Guardant Health (GH) in Q1 2026, closing a stake of 77,117 shares — an estimated $7.88M sold.

HRT Financial first reported a position in GH in Q4 2020 and held it in 12 quarters. The position peaked at $11.6M in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

HRT Financial reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 77,117 Guardant Health shares in Q1 2026, an estimated $7.88M.
HRT Financial first reported a position in Guardant Health in Q4 2020 and held it in 12 quarters.
HRT Financial's Guardant Health position peaked at $11.6M in Q1 2021.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.